Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vedolizumab”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03885713
What this trial is testing

Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 180
Large-scale testing (Phase 3)Study completedNCT02497469
What this trial is testing

An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Takeda 771
Post-approval studies (Phase 4)Study completedNCT02790138
What this trial is testing

Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis

Who this might be right for
Pouchitis
Takeda 102
Not applicableWithdrawnNCT04349449
What this trial is testing

ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice

Who this might be right for
Crohn Disease
Takeda
Testing effectiveness (Phase 2)UnknownNCT03147859
What this trial is testing

Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection

Who this might be right for
HIV-infection/AIDS
Ottawa Hospital Research Institute 10
Post-approval studies (Phase 4)Study completedNCT03142321
What this trial is testing

Defining Predictors of RT Response to Vedolizumab in IBD

Who this might be right for
Crohn Disease of Small Intestine
Washington University School of Medicine 48
Not applicableStudy completedNCT03710486
What this trial is testing

Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda 409
Large-scale testing (Phase 3)Ended earlyNCT06570772
What this trial is testing

Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio

Who this might be right for
Ulcerative Colitis
Alvotech Swiss AG 301
Post-approval studies (Phase 4)Study completedNCT07398586
What this trial is testing

The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Second Affiliated Hospital of Wenzhou Medical University 898
Not applicableStudy completedNCT07273760
What this trial is testing

VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation

Who this might be right for
Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)
AryoGen Pharmed Co. 150
Large-scale testing (Phase 3)Study completedNCT02425111
What this trial is testing

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 101
Large-scale testing (Phase 3)Not Yet RecruitingNCT06614387
What this trial is testing

Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab

Who this might be right for
Ulcerative Colitis
JAROSLAW KIERKUS 60
Early research (Phase 1)Study completedNCT02163421
What this trial is testing

Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration

Who this might be right for
Healthy
Takeda 48
Large-scale testing (Phase 3)Study completedNCT00790933
What this trial is testing

An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 2,243
Early research (Phase 1)Study completedNCT03961295
What this trial is testing

A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants

Who this might be right for
Healthy Volunteers
Takeda 24
Not applicableStudy completedNCT04344249
What this trial is testing

Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic

Who this might be right for
IBDCOVID
Nantes University Hospital 1,109
Large-scale testing (Phase 3)Study completedNCT04779307
What this trial is testing

Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Takeda 121
Not applicableActive Not RecruitingNCT07240168
What this trial is testing

CurQD as Add-On Therapy in Vedolizumab-Treated Ulcerative Colitis Patients: Retrospective Cohort Study

Who this might be right for
Ulcerative Colitis (UC)
Evinature Ltd. 400
Early research (Phase 1)Study completedNCT04112212
What this trial is testing

Using Vedolizumab-800CW to Gain Insight Into Local Drug Distribution and Mucosal Target Cells in IBD Patients

Who this might be right for
Crohn DiseaseColitis, Ulcerative
University Medical Center Groningen 38
Testing effectiveness (Phase 2)Study completedNCT03138655
What this trial is testing

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 89
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation